E
Biofrontera Inc.
BFRI
$0.729
-$0.0584-7.42%
E
Sell
3/25/2025Upgraded
Biofrontera Inc. (BFRI) was upgraded to E+ from E on 3/25/2025 due to a significant increase in the growth index, solvency index and volatility index. EBIT increased 65.48% from -$4.96M to -$1.71M, earnings per share increased from -$0.9818 to -$0.3695, and total revenue increased 39.36% from $9.01M to $12.56M.
Biofrontera Inc. (BFRI) was upgraded to E+ from E on 3/25/2025 due to a significant increase in the growth index, solvency index and volatility index. EBIT increased 65.48% from -$4.96M to -$1.71M, earnings per share increased from -$0.9818 to -$0.3695, and total revenue increased 39.36% from $9.01M to $12.56M.
E
Sell
3/12/2025Downgrade
Biofrontera Inc. (BFRI) was downgraded to E from E+ on 3/12/2025 due to a large decline in the solvency index and volatility index. Debt to equity increased from 0.09 to 0.12, and the quick ratio declined from 0.85 to 0.7.
Biofrontera Inc. (BFRI) was downgraded to E from E+ on 3/12/2025 due to a large decline in the solvency index and volatility index. Debt to equity increased from 0.09 to 0.12, and the quick ratio declined from 0.85 to 0.7.
E
Sell
3/14/2023Downgrade
Biofrontera Inc. (BFRI) was downgraded to E+ from D- on 3/14/2023 due to a decline in the solvency index and total return index.
Biofrontera Inc. (BFRI) was downgraded to E+ from D- on 3/14/2023 due to a decline in the solvency index and total return index.
D
Sell
2/23/2023Upgraded
Biofrontera Inc. (BFRI) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index.
Biofrontera Inc. (BFRI) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Biofrontera Inc. (BFRI) was downgraded to E+ from D- on 2/8/2023 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 4,852.8% from $125 to -$5.94M, earnings per share declined from -$0.05 to -$0.1129, and total revenue declined 3.03% from $4.46M to $4.32M.
Biofrontera Inc. (BFRI) was downgraded to E+ from D- on 2/8/2023 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 4,852.8% from $125 to -$5.94M, earnings per share declined from -$0.05 to -$0.1129, and total revenue declined 3.03% from $4.46M to $4.32M.
D
Sell
7/1/2022Upgraded
Biofrontera Inc. (BFRI) was upgraded to D- from E on 7/1/2022 due to a significant increase in the solvency index, growth index and valuation index. Earnings per share increased from -$1.2943 to $0.32, operating cash flow increased 89.94% from -$20.99M to -$2.11M, and EBIT increased 36.3% from -$4.88M to -$3.11M.
Biofrontera Inc. (BFRI) was upgraded to D- from E on 7/1/2022 due to a significant increase in the solvency index, growth index and valuation index. Earnings per share increased from -$1.2943 to $0.32, operating cash flow increased 89.94% from -$20.99M to -$2.11M, and EBIT increased 36.3% from -$4.88M to -$3.11M.
E
Sell
4/1/2022Upgraded
Biofrontera Inc. (BFRI) was upgraded to E from E- on 04/01/2022.
Biofrontera Inc. (BFRI) was upgraded to E from E- on 04/01/2022.
E
Sell
3/15/2022Downgrade
Biofrontera Inc. (BFRI) was downgraded to E- from E on 3/15/2022 due to a decline in the volatility index.
Biofrontera Inc. (BFRI) was downgraded to E- from E on 3/15/2022 due to a decline in the volatility index.
E
Sell
1/25/2022None
Biofrontera Inc. (BFRI) was downgraded to E from U on 01/25/2022.
Biofrontera Inc. (BFRI) was downgraded to E from U on 01/25/2022.
NASDAQ
04/04/2025 1:31PM Eastern
Quotes delayed
